CARNIVAL WKN: 120071 ISIN: GB0031215220 Kürzel: CCL Forum: Aktien Thema: Hauptdiskussion
Second quarter net income improved by nearly $500 million compared to 2023 and adjusted net income outperformed March guidance by nearly $170 million (see "Non-GAAP Financial Measures" below). Record second quarter operating income of $560 million, nearly five times 2023 levels, on record second quarter revenues of $5.8 billion. Raised full year 2024 net yield guidance (in constant currency) to approximately 10.25 percent on continued strong demand and raised full year adjusted net income guidance by approximately $275 million. Cumulative booked position for the remainder of 2024 continues to be the best on record in both price (in constant currency) and occupancy. While early, cumulative booked position for full year 2025 is even higher than 2024 in both price (in constant currency) and occupancy. Total customer deposits reached an all-time high of $8.3 billion, surpassing the previous record by $1.1 billion.
|
|
Thema | ||
|---|---|---|---|
| 1 | BTC/USD Hauptdiskussion | -4,87 % | |
| 2 | PAIN THERAPEUTICS Hauptdiskussion | -83,84 % | |
| 3 | MicroStrategy | -5,79 % | |
| 4 | Exela 2023 sachliches Forum | +5,45 % | |
| 5 | BioNTech Hauptdiskussion | +6,51 % | |
| 6 | GAMESTOP Hauptdiskussion | +5,69 % | |
| 7 | MICROSTRATEGY Hauptdiskussion | -5,79 % | |
| 8 | Neptune Sachlich | -7,70 % | |
| 9 | BED BATH & BEYOND Hauptdiskussion | ±0,00 % | |
| 10 | BP Hauptdiskussion | -1,83 % | Alle Diskussionen |
|
|
Thema | ||
|---|---|---|---|
| 1 | MicroStrategy | -5,79 % | |
| 2 | PAIN THERAPEUTICS Hauptdiskussion | -83,84 % | |
| 3 | Exela 2023 sachliches Forum | +5,45 % | |
| 4 | BioNTech Hauptdiskussion | +6,51 % | |
| 5 | GAMESTOP Hauptdiskussion | +5,69 % | |
| 6 | MICROSTRATEGY Hauptdiskussion | -5,79 % | |
| 7 | Neptune Sachlich | -7,70 % | |
| 8 | BED BATH & BEYOND Hauptdiskussion | ±0,00 % | |
| 9 | BP Hauptdiskussion | -1,83 % | |
| 10 | BAYER Hauptdiskussion | +0,62 % | Alle Diskussionen |